Genetic Engineering News and Research

RSS

Researchers eliminate need for anti-rejection drugs in mice with transplanted glial cells

In experiments in mice, Johns Hopkins Medicine researchers say they have developed a way to successfully transplant certain protective brain cells without the need for lifelong anti-rejection drugs.

16 Sep 2019

Editing away cancer and HIV in China: win or lose?

Scientists in China recently edited out the CCR5 gene from a patient with HIV's stem cells, but the research has sparked ethical debate.

13 Sep 2019

Failed cancer drug could potentially be used to treat fibrotic diseases and scleroderma

Sixteen years ago, a research group at Mayo Medical School published results showing that a protein called TRAIL can kill cells that cause liver fibrosis but no one seemed to follow up on these findings.

From Johns Hopkins Medicine 13 Sep 2019

Accelerating Nanobody Production using Polyclonal Anti-VHH Antibodies

In this interview, Dr. Dave Fancy, CEO of Jackson ImmunoResearch explains how anti-VHH antibodies can be used to produce nanobodies and VHH libraries.

From Jackson ImmunoResearch Laboratories, Inc. 12 Sep 2019

Cancer disease incidence and severity influenced by gene mutation, tissue location

The KRAS gene is one of the commonly mutated genes in cancer. More than 40 percent of colorectal cancers have a mutated KRAS gene, or oncogene, that is at least partially responsible for cancer development.

12 Sep 2019

CAR T-cell therapy may be viable treatment option for heart disease

CAR T-cell therapy, a rapidly emerging form of immunotherapy using patients' own cells to treat certain types of cancers, may be a viable treatment option for another life-threatening condition: heart disease.

12 Sep 2019

Reducing acrylamide in fried and baked snacks

In 2002, the discovery of acrylamide in certain snacks rattled consumers and the food industry. Acrylamide, a probable human carcinogen, forms by a chemical reaction during baking or frying.

11 Sep 2019

Oxford Genetics unveils OXGENE brand

Oxford Genetics Ltd announces the launch of its brand OXGENE™. The new brand articulates the company’s powerful ability to combine highly innovative science with an engineering approach to custom solutions for biotechnology.

From OXGENE 11 Sep 2019

Genetic engineering could open possibilities for patients with Parkinson’s disease

People with Parkinson’s disease experience loss of dopamine-producing brain cells, leading to tremors, rigidity, bradykinesia, and postural instability, the primary symptoms of the disease.

11 Sep 2019

Brain circuit regulates individual responses to temptation cues, rat study finds

Differences in a key brain circuit may suggest why some individuals are less able than others to resist tempting cues, according to a study in rats published today in eLife.

11 Sep 2019

'Protein mapping' approach reveals why metastatic melanoma patients do not respond to immunotherapy

Tel Aviv University and Sheba Medical Center researchers say they have discovered why more than half of patients with metastatic melanoma do not respond to immunotherapy cancer treatments.

10 Sep 2019

Is your cell phone good for your health?

Many studies have examined the health effects of smartphone abuse, but a new study looks at the sociodemographic features and health indicators of people who have a smartphone but do not use it regularly.

9 Sep 2019

Parkinson's disease may originate from the gut of patients

In 2003, a German neuropathologist proposed that Parkinson's disease, which attacks the brain, actually might originate from the gut of the patients.

3 Sep 2019

Study reshapes the understanding of telomerase's function in normal cells

New research from the University of Maryland and the National Institutes of Health reveals a new role for the enzyme telomerase.

3 Sep 2019

SATI gene editing could replace CRISPR

Scientists have developed a new gene editing tool called SATI that is safer than CRISPR.

2 Sep 2019

Diet can alter efficacy of type-2 diabetes drug via its action on gut bacteria, study shows

Research published in Cell on 29th August by the groups of Filipe Cabreiro from the MRC London Institute of Medical Sciences and Imperial College and Christoph Kaleta from Kiel University in Germany has demonstrated that diet can alter the effectiveness of a type-2 diabetes drug via its action on gut bacteria.

30 Aug 2019

Study opens up new ways to understand the cause of chronic viral arthritis

Since chikungunya virus emerged in the Americas in 2013, it has infected millions of people, causing fever, headache, rash, and muscle and joint pain.

29 Aug 2019

UC San Francisco scientists identify second 'short sleep' gene after 10-year search

After a decade of searching, the UC San Francisco scientists who identified the only human gene known to promote "natural short sleep" -- lifelong, nightly sleep that lasts just four to six hours yet leaves individuals feeling fully rested -- have discovered a second.

28 Aug 2019

New study helps explain why lung tumors turn aggressive

Lung cancer is the number 1 killer among cancers, especially when it is of the non-small cell type. Among these, adenocarcinomas are the most common and aggressive type. These tumors also show a strong tendency to show dedifferentiation, or loss of the features that characterize a mature lung cell.

28 Aug 2019

Researchers gain new insights into types of germ cell tumors

Germ cell tumors constitute a diverse group of rare tumors, which occur in the testes, ovaries and also in other places. Some germ cell tumors exist prenatally, while others present during or after puberty. The majority is benign.

27 Aug 2019

Genetic Engineering News and Research

Researchers eliminate need for anti-rejection drugs in mice with transplanted glial cells

Editing away cancer and HIV in China: win or lose?

Failed cancer drug could potentially be used to treat fibrotic diseases and scleroderma

Accelerating Nanobody Production using Polyclonal Anti-VHH Antibodies

Cancer disease incidence and severity influenced by gene mutation, tissue location

CAR T-cell therapy may be viable treatment option for heart disease

Reducing acrylamide in fried and baked snacks

Oxford Genetics unveils OXGENE brand

Genetic engineering could open possibilities for patients with Parkinson’s disease

Brain circuit regulates individual responses to temptation cues, rat study finds

'Protein mapping' approach reveals why metastatic melanoma patients do not respond to immunotherapy

Is your cell phone good for your health?

Parkinson's disease may originate from the gut of patients

Study reshapes the understanding of telomerase's function in normal cells

SATI gene editing could replace CRISPR

Diet can alter efficacy of type-2 diabetes drug via its action on gut bacteria, study shows

Study opens up new ways to understand the cause of chronic viral arthritis

UC San Francisco scientists identify second 'short sleep' gene after 10-year search

New study helps explain why lung tumors turn aggressive

Researchers gain new insights into types of germ cell tumors

Genetics & Genomics - Second Edition eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News